PVI
ABEO icon

Pura Vida Investments’s Abeona Therapeutics ABEO Stock Holding History

Pura Vida Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,454
Closed -$391K – 122
2020
Q1 		$391K Sell
7,454
-2,356
-24% -$157K 0.05% 89
2019
Q4 		$802K Buy
+9,810
New +$692K 0.07% 94

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Pura Vida Investments's ABEO Position: Q2 2020 in Review

Pura Vida Investments sold out of Abeona Therapeutics (ABEO) in Q2 2020, closing a stake of 7,454 shares — an estimated $391K sold.

Pura Vida Investments first reported a position in ABEO in Q4 2019 and held it in 2 quarters. The position peaked at $802K in Q4 2019. 83 funds tracked by Wall St. Rank hold ABEO as of Q2 2020.

  • Pura Vida Investments reported no remaining Abeona Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Pura Vida Investments sold 7,454 Abeona Therapeutics shares in Q2 2020, an estimated $391K.
  • Pura Vida Investments first reported a position in Abeona Therapeutics in Q4 2019 and held it in 2 quarters.
  • Pura Vida Investments's Abeona Therapeutics position peaked at $802K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2020.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.